Hollak CE - Search Results

1

Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease.

van Breemen MJ, de Fost M, Voerman JS, Laman JD, Boot RG, Maas M, Hollak CE, Aerts JM, Rezaee F. van Breemen MJ, et al. Among authors: hollak ce. Biochim Biophys Acta. 2007 Jul;1772(7):788-96. doi: 10.1016/j.bbadis.2007.04.002. Epub 2007 Apr 14. Biochim Biophys Acta. 2007. PMID: 17499484 Free article.

2

[Gaucher's disease; current developments in the treatment of lysosomal metabolic disease].

Hollak CE, Aerts JM, Goudsmit R. Hollak CE, et al. Ned Tijdschr Geneeskd. 1991 Nov 16;135(46):2162-4. Ned Tijdschr Geneeskd. 1991. PMID: 1956441 Review. Dutch. No abstract available.

3

Increased basal glucose production in type 1 Gaucher's disease.

Corssmit EP, Hollak CE, Endert E, van Oers MH, Sauerwein HP, Romijn JA. Corssmit EP, et al. Among authors: hollak ce. J Clin Endocrinol Metab. 1995 Sep;80(9):2653-7. doi: 10.1210/jcem.80.9.7673407. J Clin Endocrinol Metab. 1995. PMID: 7673407

4

Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.

Hollak CE, Aerts JM, Goudsmit R, Phoa SS, Ek M, van Weely S, von dem Borne AE, van Oers MH. Hollak CE, et al. Lancet. 1995 Jun 10;345(8963):1474-8. doi: 10.1016/s0140-6736(95)91037-9. Lancet. 1995. PMID: 7769902 Clinical Trial.

5

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Hollak CE, van Weely S, van Oers MH, Aerts JM. Hollak CE, et al. J Clin Invest. 1994 Mar;93(3):1288-92. doi: 10.1172/JCI117084. J Clin Invest. 1994. PMID: 8132768 Free PMC article.

6

Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease.

Aerts JM, Van Weely S, Boot R, Hollak CE, Tager JM. Aerts JM, et al. Among authors: hollak ce. J Inherit Metab Dis. 1993;16(2):288-91. doi: 10.1007/BF00710267. J Inherit Metab Dis. 1993. PMID: 8411983 Review. No abstract available.

7

Treatment of Gaucher's disease.

Hollak CE, Aerts JM, van Oers MH. Hollak CE, et al. N Engl J Med. 1993 May 27;328(21):1565-6; author reply 1567. N Engl J Med. 1993. PMID: 8479498 No abstract available.

8

[The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].

Hollak CE, van Oers MH, Maaswinkel P, Aerts JM, Goudsmit R. Hollak CE, et al. Ned Tijdschr Geneeskd. 1996 May 11;140(19):1011-3. Ned Tijdschr Geneeskd. 1996. PMID: 8684492 Review. Dutch. No abstract available.

9

Elevated plasma chitotriosidase activity in various lysosomal storage disorders.

Guo Y, He W, Boer AM, Wevers RA, de Bruijn AM, Groener JE, Hollak CE, Aerts JM, Galjaard H, van Diggelen OP. Guo Y, et al. Among authors: hollak ce. J Inherit Metab Dis. 1995;18(6):717-22. doi: 10.1007/BF02436762. J Inherit Metab Dis. 1995. PMID: 8750610

10

The effect of enzyme therapy in a patient with Gaucher disease type III.

Bosman DK, Hollak CE, Aerts JM, Bakker HD. Bosman DK, et al. Among authors: hollak ce. J Inherit Metab Dis. 1996;19(5):703-4. doi: 10.1007/BF01799852. J Inherit Metab Dis. 1996. PMID: 8892032 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters